Skip to main content

Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy.

Publication ,  Journal Article
Djomand, G; Beyrer, C; Buchbinder, S
Published in: J Acquir Immune Defic Syndr
December 15, 2008

Duke Scholars

Published In

J Acquir Immune Defic Syndr

DOI

ISSN

1525-4135

Publication Date

December 15, 2008

Volume

49

Issue

5

Start / End Page

570

Location

United States

Related Subject Headings

  • Virology
  • Sex Work
  • Risk Factors
  • Prospective Studies
  • Patient Selection
  • Incidence
  • Humans
  • HIV Seroprevalence
  • HIV Seropositivity
  • HIV Seronegativity
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Djomand, G., Beyrer, C., & Buchbinder, S. (2008). Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy. J Acquir Immune Defic Syndr, 49(5), 570. https://doi.org/10.1097/QAI.0b013e31818d5f9e
Djomand, Gaston, Chris Beyrer, and Susan Buchbinder. “Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy.J Acquir Immune Defic Syndr 49, no. 5 (December 15, 2008): 570. https://doi.org/10.1097/QAI.0b013e31818d5f9e.
Djomand G, Beyrer C, Buchbinder S. Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy. J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):570.
Djomand, Gaston, et al. “Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy.J Acquir Immune Defic Syndr, vol. 49, no. 5, Dec. 2008, p. 570. Pubmed, doi:10.1097/QAI.0b013e31818d5f9e.
Djomand G, Beyrer C, Buchbinder S. Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy. J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):570.

Published In

J Acquir Immune Defic Syndr

DOI

ISSN

1525-4135

Publication Date

December 15, 2008

Volume

49

Issue

5

Start / End Page

570

Location

United States

Related Subject Headings

  • Virology
  • Sex Work
  • Risk Factors
  • Prospective Studies
  • Patient Selection
  • Incidence
  • Humans
  • HIV Seroprevalence
  • HIV Seropositivity
  • HIV Seronegativity